CNS Pharmaceuticals (CNSP) Times Interest Earned (2018 - 2025)
CNS Pharmaceuticals' (CNSP) quarterly Times Interest Earned came in at -$2200.0 in Q4 2025, up 82.61% YoY from -$1204.8 in Q4 2024, and down 43.09% on a QoQ basis from -$1537.5 in Q3 2025.
CNS Pharmaceuticals (CNSP) Times Interest Earned (2018 - 2025) Analysis & Trends
CNS Pharmaceuticals (CNSP) has 8 years of Times Interest Earned data on file, last reported at -$2200.0 in Q4 2025.
- Quarterly Times Interest Earned rose 82.61% year-over-year to -$2200.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1049.7 (up 4.21% YoY) and the FY2025 annual result came in at -$0.85, up 12.79% from the prior year.
- Times Interest Earned slipped to -$2200.0 in Q4 2025, from -$1537.5 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$87.04 in Q2 2023 to a low of -$12648.4 in Q4 2024.
- A 5-year average of -$2205.8 and a median of -$1393.1 in 2021 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned surged 96.07% — and 2024, when it slumped 577.4%.
- Tracing CNSP's Times Interest Earned over 5 years: stood at -$1266.7 in 2021, then dropped by 19.96% to -$1519.5 in 2022, then decreased by 22.88% to -$1867.2 in 2023, then slumped by 577.4% to -$12648.4 in 2024, then jumped by 82.61% to -$2200.0 in 2025.
- The last three Times Interest Earned figures came in at -$2200.0 (Q4 2025), -$1537.5 (Q3 2025), and -$575.72 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | CNS Pharmaceuticals | 2.65 Mn | -4.55 Mn | - | -2,199.97 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,199.97 |
| Sep 30, 2025 | -1,537.52 |
| Jun 30, 2025 | -575.72 |
| Mar 31, 2025 | -698.72 |
| Dec 31, 2024 | -12,648.41 |
| Sep 30, 2024 | -2,492.87 |
| Jun 30, 2024 | -566.47 |
| Mar 31, 2024 | -535.07 |
| Dec 31, 2023 | -1,867.19 |
| Sep 30, 2023 | -1,049.99 |
| Jun 30, 2023 | -87.04 |
| Mar 31, 2023 | -906.28 |
| Dec 31, 2022 | -1,519.54 |
| Sep 30, 2022 | -6,355.05 |
| Jun 30, 2022 | -2,212.50 |
| Mar 31, 2022 | -1,092.34 |
| Dec 31, 2021 | -1,266.67 |
| Sep 30, 2021 | -4,026.82 |
| Jun 30, 2021 | -1,619.77 |
| Mar 31, 2021 | -857.81 |